Skip to main content

Building

A better future

through education, skill development and research

LEARN MORE

Certain Psychiatric Drugs Linked with Elevated Pneumonia Risk

A review of published studies indicates that use of benzodiazepines and benzodiazepine related drugs (BZRDs), which are prescribed to treat various psychiatric diseases, may increase the risk of pneumonia.

The International Journal of Geriatric Psychiatry analysis included 12 reports related to 10 studies involving more than 120,000 pneumonia cases.

Wednesday, January 9, 2019 12:01 am EST

A review of published studies indicates that use of benzodiazepines and benzodiazepine related drugs (BZRDs), which are prescribed to treat various psychiatric diseases, may increase the risk of pneumonia.

The International Journal of Geriatric Psychiatry analysis included 12 reports related to 10 studies involving more than 120,000 pneumonia cases. After pooling the estimates, the odds for developing pneumonia were 1.25-fold higher in BZRD users compared with individuals who had not taken BZRDs.

There was an increased risk of pneumonia among current and recent users, but not past users.

Additional Information

Link to Study: https://onlinelibrary.wiley.com/doi/full/10.1002/gps.5048  

About Journal 

The rapidly increasing world population of aged people has led to a growing need to focus attention on the problems of mental disorder in late life. The aim of the Journal is to communicate the results of original research in the causes, treatment and care of all forms of mental disorder which affect the elderly. The Journal is of interest to psychiatrists, psychologists, social scientists, nurses and others engaged in therapeutic professions, together with general neurobiological researchers.

The Journal provides an international perspective on the important issue of geriatric psychiatry, and contributions are published from countries throughout the world. Topics covered include epidemiology of mental disorders in old age, clinical aetiological research, post-mortem pathological and neurochemical studies, treatment trials and evaluation of geriatric psychiatry services.

About Wiley

Wiley is a global leader in research and education. Our online scientific, technical, medical, and scholarly journals, and our digital learning, assessment, certification and student-lifecycle services and solutions help universities, academic societies, businesses, governments and individuals to achieve their academic and professional goals. For more than 200 years, we have delivered consistent performance to our stakeholders. The Company's website can be accessed at www.wiley.com.

Multimedia Files:

Preview image

Contact:

Josh Glickman +1 201-748-6572 (US)
Penny Smith +44 (0) 1243 770448 (UK)
newsroom@wiley.com

Business Wire NewsHQsm